Detalhe da pesquisa
1.
Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma.
Proc Natl Acad Sci U S A
; 115(31): E7351-E7360, 2018 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021854
2.
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis.
Cancer Res
; 81(16): 4319-4331, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145035
3.
Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative Proliferation.
Cell Rep
; 12(6): 1019-31, 2015 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26235622
4.
Molecular pathways: harnessing E2F1 regulation for prosenescence therapy in p53-defective cancer cells.
Clin Cancer Res
; 20(14): 3644-50, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24788101
5.
Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.
Cancer Discov
; 3(2): 182-97, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23306062
6.
Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells.
Cancer Res
; 73(22): 6757-69, 2013 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24072747
7.
CIP2A is associated with human breast cancer aggressivity.
Clin Cancer Res
; 15(16): 5092-100, 2009 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19671842